vs

Side-by-side financial comparison of Camden Property Trust (CPT) and Moolec Science SA (MLEC). Click either name above to swap in a different company.

Camden Property Trust is the larger business by last-quarter revenue ($5.3M vs $2.6M, roughly 2.0× Moolec Science SA). Camden Property Trust runs the higher net margin — 2954.1% vs -91.8%, a 3045.9% gap on every dollar of revenue.

Camden Property Trust is a publicly traded real estate investment trust that invests in apartments in the United States. As of December 31, 2023, the company owned interests in 176 apartment communities containing 59,800 apartment homes in the United States. It is the 14th largest owner of apartments in the United States.

Moolec Science SA is a global agricultural biotechnology and food technology company specializing in molecular farming. It uses engineered crop platforms to produce sustainable, cost-competitive animal-derived proteins for use in alternative meat, dairy products and food ingredients, serving food manufacturers, agribusinesses and consumer goods brands across North America, Europe and Latin America.

CPT vs MLEC — Head-to-Head

Bigger by revenue
CPT
CPT
2.0× larger
CPT
$5.3M
$2.6M
MLEC
Higher net margin
CPT
CPT
3045.9% more per $
CPT
2954.1%
-91.8%
MLEC

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CPT
CPT
MLEC
MLEC
Revenue
$5.3M
$2.6M
Net Profit
$156.0M
$-2.4M
Gross Margin
-25.5%
Operating Margin
-77.9%
Net Margin
2954.1%
-91.8%
Revenue YoY
243.0%
Net Profit YoY
283.5%
EPS (diluted)
$1.44
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPT
CPT
MLEC
MLEC
Q4 25
$5.3M
Q3 25
$2.6M
Q2 25
$2.6M
Q1 25
$2.5M
Q4 24
$1.5M
$2.6M
Q3 24
$1.7M
Q2 24
$2.6M
Q1 24
$1.3M
Net Profit
CPT
CPT
MLEC
MLEC
Q4 25
$156.0M
Q3 25
$108.9M
Q2 25
$80.7M
Q1 25
$38.8M
Q4 24
$40.7M
$-2.4M
Q3 24
$-4.2M
Q2 24
$42.9M
Q1 24
$83.9M
Gross Margin
CPT
CPT
MLEC
MLEC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-25.5%
Q3 24
Q2 24
Q1 24
Operating Margin
CPT
CPT
MLEC
MLEC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-77.9%
Q3 24
Q2 24
Q1 24
Net Margin
CPT
CPT
MLEC
MLEC
Q4 25
2954.1%
Q3 25
4246.9%
Q2 25
3063.8%
Q1 25
1561.0%
Q4 24
2642.3%
-91.8%
Q3 24
-246.3%
Q2 24
1646.9%
Q1 24
6533.4%
EPS (diluted)
CPT
CPT
MLEC
MLEC
Q4 25
$1.44
Q3 25
$1.00
Q2 25
$0.74
Q1 25
$0.36
Q4 24
$0.37
$-0.06
Q3 24
$-0.04
Q2 24
$0.40
Q1 24
$0.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPT
CPT
MLEC
MLEC
Cash + ST InvestmentsLiquidity on hand
$25.2M
$1.9M
Total DebtLower is stronger
$3.9B
Stockholders' EquityBook value
$4.4B
$2.8M
Total Assets
$9.0B
$31.4M
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPT
CPT
MLEC
MLEC
Q4 25
$25.2M
Q3 25
$25.9M
Q2 25
$33.1M
Q1 25
$26.2M
Q4 24
$21.0M
$1.9M
Q3 24
$31.2M
Q2 24
$93.9M
Q1 24
$92.7M
Total Debt
CPT
CPT
MLEC
MLEC
Q4 25
$3.9B
Q3 25
$3.7B
Q2 25
$3.8B
Q1 25
$3.7B
Q4 24
$3.5B
Q3 24
$3.5B
Q2 24
$3.6B
Q1 24
$3.6B
Stockholders' Equity
CPT
CPT
MLEC
MLEC
Q4 25
$4.4B
Q3 25
$4.5B
Q2 25
$4.6B
Q1 25
$4.6B
Q4 24
$4.7B
$2.8M
Q3 24
$4.7B
Q2 24
$4.9B
Q1 24
$4.9B
Total Assets
CPT
CPT
MLEC
MLEC
Q4 25
$9.0B
Q3 25
$9.1B
Q2 25
$9.1B
Q1 25
$9.0B
Q4 24
$8.9B
$31.4M
Q3 24
$8.9B
Q2 24
$9.1B
Q1 24
$9.1B
Debt / Equity
CPT
CPT
MLEC
MLEC
Q4 25
0.89×
Q3 25
0.82×
Q2 25
0.83×
Q1 25
0.81×
Q4 24
0.75×
Q3 24
0.73×
Q2 24
0.73×
Q1 24
0.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPT
CPT
MLEC
MLEC
Operating Cash FlowLast quarter
$826.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
4.4%
Cash ConversionOCF / Net Profit
5.30×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPT
CPT
MLEC
MLEC
Q4 25
$826.6M
Q3 25
$250.9M
Q2 25
$230.7M
Q1 25
$148.2M
Q4 24
$774.9M
Q3 24
$261.6M
Q2 24
$225.1M
Q1 24
$135.9M
Capex Intensity
CPT
CPT
MLEC
MLEC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
4.4%
Q3 24
Q2 24
Q1 24
Cash Conversion
CPT
CPT
MLEC
MLEC
Q4 25
5.30×
Q3 25
2.30×
Q2 25
2.86×
Q1 25
3.82×
Q4 24
19.04×
Q3 24
Q2 24
5.24×
Q1 24
1.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons